Hatteras Venture Partners IV SBIC LP 13D/13G Filings for G1 Therapeutics, Inc. (GTHX)

Hatteras Venture Partners IV SBIC LP 13D and 13G filings for G1 Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-12
4:16 pm
Sale		 2020-12-31 13G G1 Therapeutics, Inc.
GTHX		 Hatteras Venture Partners IV SBIC LP 1,756,462
4.600%		 -259,926decrease
(-12.89%)		 Filing